Cannabis and the Developing Brain

·
· Academic Press
電子書
360
頁數
符合資格
評分和評論未經驗證 瞭解詳情

關於這本電子書

Marijuana is the most commonly used psychotropic drug in the United States, after alcohol. With the legalization and decriminalization of cannabis, momentum continues to build and propelled by the reduction of stigma associated to its consumption, there is growing concern regarding the long-term impact on brain function and behavior. Cannabis and the Developing Brain aims to provide comprehensive research on the effects of cannabis during neurodevelopment stages (i.e., perinatal and adolescent ages). This book introduces readers to vivo neural circuits, molecular and cellular mechanisms affected by cannabis exposure during three different temporal windows of brain vulnerability. Second, it offers a unique insight to shared neurobiological features of cannabinoid exposure during different developmental periods. Lastly, Cannabis and the Developing Brain determines the adverse impact of developmental cannabinoid exposure on specific cognition, emotion and behaviors. - Reviews exposure effects on different areas and circuits of the brain - Identifies effects of exposure at prenatal, perinatal, infant, and adolescent ages - Includes cannabis interaction with known genetic and environmental risk factors - Contains neurodevelopment and neuropsychiatric disorders associated with cannabis exposure

關於作者

Miriam Melis is an Associate Professor at the University of Cagliari, Italy. She holds a PharmD (University of Palermo, 1993) as well as a PhD in Neuroscience (University of Cagliari, 2011). During her career she worked as a Research Fellow for two years at the Ernest Gallo Clinic and Research Center at UCSF and as a Visiting Scientist at Lund Universitet Wallenberg Neuroscience Center in 2011. Her research is focused on understanding neurobiological mechanisms (i.e., adaptations of both mesocorticolimbic dopamine and endocannabinoid signaling) of resilience and susceptibility to adverse neurodevelopmental outcomes leading to neuropsychiatric disorders (e.g., psychotic- spectrum, substance use disorder, antisocial behavior, anxiety, depression). She has published 46 research papers, 5 book chapters and edited two books specifically on the effects of (endo)cannabinoids in the CNS.

Olivier Manzoni is a Research Director at INSERM in Marseille and director of the International Associated Laboratory CannaLab (University of Indiana, Bloomington USA / Aix-Marseille University, France). His research is centered on understanding the molecular basis of synaptic plasticity in normal and pathological conditions, with a focus on the function of the endocannabinoid system and the effects of cannabis during lifetime.

為這本電子書評分

請分享你的寶貴意見。

閱讀資訊

智能手機和平板電腦
請安裝 Android 版iPad/iPhone 版「Google Play 圖書」應用程式。這個應用程式會自動與你的帳戶保持同步,讓你隨時隨地上網或離線閱讀。
手提電腦和電腦
你可以使用電腦的網絡瀏覽器聆聽在 Google Play 上購買的有聲書。
電子書閱讀器及其他裝置
如要在 Kobo 等電子墨水裝置上閱覽書籍,你需要下載檔案並傳輸到你的裝置。請按照說明中心的詳細指示,將檔案傳輸到支援的電子書閱讀器。